Upgrade to SI Premium - Free Trial

Vivos Therapeutics (VVOS) PT Lowered to $2.50 at H.C. Wainwright

April 20, 2026 6:37 AM
(Updated - April 20, 2026 6:38 AM EDT)

H.C. Wainwright analyst Yi Chen lowered the price target on Vivos ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change